Royce & Associates LP Sells 8,730 Shares of RadNet, Inc. $RDNT

Royce & Associates LP lowered its stake in shares of RadNet, Inc. (NASDAQ:RDNT) by 6.5% during the third quarter, HoldingsChannel reports. The fund owned 124,859 shares of the medical research company’s stock after selling 8,730 shares during the quarter. Royce & Associates LP’s holdings in RadNet were worth $9,516,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of RDNT. Ninepoint Partners LP acquired a new stake in RadNet in the 3rd quarter worth $163,000. Aster Capital Management DIFC Ltd acquired a new position in shares of RadNet during the third quarter valued at about $73,000. Xponance Inc. raised its position in shares of RadNet by 3.7% during the third quarter. Xponance Inc. now owns 5,368 shares of the medical research company’s stock valued at $409,000 after buying an additional 193 shares during the last quarter. Westfield Capital Management Co. LP bought a new stake in shares of RadNet in the third quarter valued at about $40,073,000. Finally, US Bancorp DE grew its position in RadNet by 485.4% during the third quarter. US Bancorp DE now owns 28,350 shares of the medical research company’s stock worth $2,161,000 after buying an additional 23,507 shares in the last quarter. 77.90% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on RDNT. Raymond James Financial restated a “strong-buy” rating on shares of RadNet in a research note on Thursday, December 18th. B. Riley Financial lifted their price objective on RadNet from $71.00 to $87.00 and gave the stock a “buy” rating in a report on Monday, December 1st. The Goldman Sachs Group upgraded RadNet to a “buy” rating in a research note on Tuesday, December 16th. Zacks Research cut RadNet from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 12th. Finally, KeyCorp upgraded shares of RadNet to a “strong-buy” rating in a research note on Friday, January 9th. Two equities research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $90.43.

Key Headlines Impacting RadNet

Here are the key news stories impacting RadNet this week:

• Positive Sentiment: RadNet announced the acquisition of Gleamer (priced up to €230M / ~$269–270M), integrating the Paris‑based radiology AI vendor into its DeepHealth unit to create the largest clinical radiology AI provider worldwide; management expects material ARR and product breadth gains. RadNet Acquires Gleamer (Business Insider)
• Positive Sentiment: RadNet reported record Q4 revenue and adjusted EBITDA, beat EPS and top‑line estimates (Q4 revenue ~$547.7M; EPS $0.23 vs $0.19 consensus) and highlighted a strong digital health segment (digital revenue reported up ~48%), supporting growth expectations. RadNet Reports Fourth Quarter 2025 Results (GlobeNewswire)
• Neutral Sentiment: Management issued FY‑2026 revenue guidance (~$2.5B vs. ~$2.3B consensus) — a bullish signal for growth but guidance includes forward‑looking assumptions tied to DeepHealth scale‑up and Gleamer integration. Q4 Results & 2026 Guidance (GlobeNewswire)
• Neutral Sentiment: Management is engaging investors: CFO presenting at Raymond James conference and RadNet scheduled an investor call and webcast to discuss the Gleamer deal and Q4 results — good opportunities for further detail on expected synergies and financing. Raymond James Presentation (GlobeNewswire)
• Negative Sentiment: The Gleamer purchase is an all‑cash deal (plus milestones) of up to €230M — this raises near‑term cash/debt and execution risk (integration, realization of projected ARR to ~$140M by year‑end 2026). Investors will watch capital allocation, near‑term leverage and cash flow impact. Acquisition Details & Risks (QuiverQuant)
• Negative Sentiment: While revenue and some metrics beat estimates, RadNet still reported a small negative GAAP net margin and has meaningful integration and execution uncertainties; additional disclosure on cost synergies and timelines remains critical. Earnings Call Transcript (Seeking Alpha)

RadNet Trading Down 3.5%

RDNT stock opened at $72.58 on Wednesday. RadNet, Inc. has a 1-year low of $45.00 and a 1-year high of $85.84. The company has a current ratio of 1.87, a quick ratio of 1.87 and a debt-to-equity ratio of 0.82. The business’s 50 day moving average is $71.67 and its 200-day moving average is $74.45. The firm has a market cap of $5.60 billion, a P/E ratio of -290.32 and a beta of 1.49.

RadNet (NASDAQ:RDNT) last announced its quarterly earnings results on Monday, March 2nd. The medical research company reported $0.23 EPS for the quarter, beating the consensus estimate of $0.19 by $0.04. RadNet had a positive return on equity of 2.60% and a negative net margin of 0.91%.The business had revenue of $547.71 million for the quarter, compared to analyst estimates of $515.67 million. During the same quarter in the previous year, the firm earned $0.22 EPS. RadNet’s quarterly revenue was up 14.8% on a year-over-year basis. Equities analysts anticipate that RadNet, Inc. will post 0.56 earnings per share for the current fiscal year.

About RadNet

RadNet, Inc is a leading independent provider of outpatient diagnostic imaging services in the United States. Through a nationwide network of fixed-site imaging centers and affiliated joint-venture locations, the company delivers a comprehensive suite of radiology services including MRI, CT, PET/CT, ultrasound, X-ray, mammography, bone densitometry, nuclear medicine and interventional radiology procedures. RadNet also offers teleradiology and imaging management solutions to physician practices, hospitals and healthcare systems.

Founded in 1981 and headquartered in Los Angeles, RadNet has expanded its footprint organically and through strategic acquisitions.